DCF — PIEDMONT MACON MEDICAL CENTER
Enterprise Value: $-577.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-577.1M
Enterprise Value
$-177.7M
PV of Cash Flows
$-399.4M
PV of Terminal Value
$-643.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $216.0M | $-38.6M | -18.0% | $-47.8M | $-43.4M |
| Year 2 | $222.4M | $-37.5M | -17.0% | $-47.0M | $-38.8M |
| Year 3 | $229.1M | $-36.4M | -16.0% | $-46.1M | $-34.6M |
| Year 4 | $236.0M | $-36.3M | -15.0% | $-46.3M | $-31.6M |
| Year 5 | $243.1M | $-36.8M | -15.0% | $-47.1M | $-29.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-577.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$209.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18380182837902467
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5